<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-943
Date of Submission: 2025-06-26

This report was submitted by a Patient from Lynch and Sons Medical Center concerning patient ANON-PX-3725. The subject is an adult other with a significant medical history including migraines, seasonal allergies, anxiety, atrial fibrillation. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Lisinopril (ACE inhibitor) administered via the Intravenous route at a dosage of 481mg, initiated on 2025-04-15 for Hypertension and discontinued on 2025-05-20; Gabapentin (Anticonvulsant) administered via the Topical route at a dosage of 103mg, initiated on 2025-04-15 for Neuropathic pain and discontinued on 2025-05-20.

On approximately 2025-04-28, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Diarrhea, Nausea. The Diarrhea was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. The Nausea was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Audience these those ability police.</data>
report_id: ADR-2025-943
report_date: '2025-06-26'
patient_details:
  patient_id: ANON-PX-3725
  gender: Other
  relevant_history:
  - migraines
  - seasonal allergies
  - anxiety
  - atrial fibrillation
suspected_drugs:
- drug_name: Lisinopril
  dosage: 481mg
  route_of_administration: Intravenous
  start_date: '2025-04-15'
  indication_for_use: Hypertension
  drug_class: ACE inhibitor
  end_date: '2025-05-20'
- drug_name: Gabapentin
  dosage: 103mg
  route_of_administration: Topical
  start_date: '2025-04-15'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2025-05-20'
adverse_reactions:
- symptom_name: Diarrhea
  onset_date: '2025-04-28'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: true
- symptom_name: Nausea
  onset_date: '2025-04-28'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
reporting_facility: Lynch and Sons Medical Center
reporter_type: Patient
notes: Audience these those ability police.
